A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.

The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

Researchers at Penn Medicine conducted a pilot randomized controlled trial to test the hypothesis that an e-triage ...

Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...

Apple cider vinegar is fermented juice made from apples. It may be useful in blood sugar management, weight loss, and ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...